Most Popular Articles

Polycystic ovary syndrome: is the cardiometabolic risk increased after menopause?

Alur-Gupta, Snigdha; Dokras, Anuja

Menopause. 26(3):331-333, March 2019.

Free

Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse

Rahkola-Soisalo, Päivi; Savolainen-Peltonen, Hanna; Gissler, Mika; More

Menopause. 26(2):140-144, February 2019.

Menopausal symptoms: not just estrogen deficiency

Brzezinski, Amnon

Menopause. 26(3):229-230, March 2019.

Physical performance in relation to menopause status and physical activity

Bondarev, Dmitriy; Laakkonen, Eija K.; Finni, Taija; More

Menopause. 25(12):1432-1441, December 2018.

Open
SDC

The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women

Moral, Eloy; Delgado, Juan L.; Carmona, Francisco; More

Menopause. 25(12):1418-1423, December 2018.

Open
SDC

WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history

Kingsberg, Sheryl A.; Larkin, Lisa; Krychman, Michael; More

Menopause. 26(2):124-131, February 2019.

Open

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Free

Small study, big questions!

Richardson, Marcie K.

Menopause. 26(3):231-232, March 2019.

Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results

Athanasiou, Stavros; Pitsouni, Eleni; Grigoriadis, Themos; More

Menopause. 26(3):248-255, March 2019.

Menopausal symptoms in different substages of perimenopause and their relationships with social support and resilience

Zhao, Di; Liu, Chunqin; Feng, Xiujuan; More

Menopause. 26(3):233-239, March 2019.

Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

Prague, Julia K.; Roberts, Rachel E.; Comninos, Alexander N.; More

Menopause. 25(8):862-869, August 2018.

Open
SDC

Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells

Seeger, Harald; Wallwiener, Diethelm; Mueck, Alfred O.

Menopause. 8(1):5-9, January 2001.

Free

The many menopauses: searching the cognitive research literature for menopause types

Edwards, Hannaford; Duchesne, Annie; Au, April S.; More

Menopause. 26(1):45-65, January 2019.

Open
SDC

Sexual activity and function assessment in middle-aged Chinese women using the female sexual function index

Zhang, Caiyun; Cui, Liping; Zhang, Lizhi; More

Menopause. 24(6):669-676, June 2017.

Open

Tissue selective estrogen complex (TSEC): a review

Pickar, James H.; Boucher, Matthieu; Morgenstern, Diana

Menopause. 25(9):1033-1045, September 2018.

Open
SDC

Effect of high-intensity interval training on body composition and inflammatory markers in obese postmenopausal women: a randomized controlled trial

Nunes, Paulo R.P.; Martins, Fernanda M.; Souza, Aletéia P.; More

Menopause. 26(3):256-264, March 2019.

A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom

Kroll, Robin; Archer, David F.; Lin, Yuhua; More

Menopause. 25(2):133-138, February 2018.

Open

Assessment of NAMS members’ prescription patterns of hormone therapy before and after the 2016 NAMS Annual Meeting

Bonnett, Lindsay P.; Jiang, Xuezhi; Pinkerton, JoAnn V.; More

Menopause. 26(3):240-247, March 2019.

Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study

Miller, Virginia M.; Hodis, Howard N.; Lahr, Brian D.; More

Menopause. 26(1):24-31, January 2019.

Open
SDC

Association of menopause and type 2 diabetes mellitus

Ren, Yongcheng; Zhang, Ming; Liu, Yu; More

Menopause. 26(3):325-330, March 2019.

Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis

Soman, Midhun; Huang, Li-Cong; Cai, Wen-Hui; More

Menopause. 26(1):78-93, January 2019.

Open
SDC

Why the product labeling for low-dose vaginal estrogen should be changed

Manson, JoAnn E.; Goldstein, Steven R.; Kagan, Risa; More

Menopause. 21(9):911-916, September 2014.

Free

Prevalence of osteopenia and osteoporosis in Thai women

Limpaphayom, Khunying Kobchitt; Taechakraichana, Nimit; Jaisamrarn, Unnop; More

Menopause. 8(1):65-69, January 2001.

Free

Effects of stretching on menopausal and depressive symptoms in middle-aged women: a randomized controlled trial

Kai, Yuko; Nagamatsu, Toshiya; Kitabatake, Yoshinori; More

Menopause. 23(8):827-832, August 2016.

Open

Clinician knowledge, attitudes, and barriers to management of vulvovaginal atrophy: variations in primary care and gynecology

Vesco, Kimberly K.; Beadle, Kate; Stoneburner, Ashley; More

Menopause. 26(3):265-272, March 2019.

Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial

Yoshikata, Remi; Myint, Khin Z.; Ohta, Hiroaki; More

Menopause. 26(3):273-285, March 2019.

What's in a name: are menopausal “hot flashes” a symptom of menopause or a manifestation of neurovascular dysregulation?

Miller, Virginia M.; Kling, Juliana M.; Files, Julia A.; More

Menopause. 25(6):700-703, June 2018.

Open

Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations

Maki, Pauline M.; Kornstein, Susan G.; Joffe, Hadine; More

Menopause. 25(10):1069-1085, October 2018.

The 2017 hormone therapy position statement of The North American Menopause Society

Menopause. 24(7):728-753, July 2017.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

Crandall, Carolyn J.; Hovey, Kathleen M.; Andrews, Christopher A.; More

Menopause. 25(1):11-20, January 2018.

Prescribing of FDA-approved and compounded hormone therapy differs by specialty

Constantine, Ginger D.; Archer, David F.; Graham, Shelli; More

Menopause. 23(10):1075-1082, October 2016.

Open
SDC

Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women

Machado, Murilo Renato Matos; de Sousa Almeida-Filho, Benedito; De Luca Vespoli, Heloisa; More

Menopause. 26(3):293-299, March 2019.

Design and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study with 47 to 55-year-old women's cohort: novel results show menopause-related differences in blood count

Kovanen, Vuokko; Aukee, Pauliina; Kokko, Katja; More

Menopause. 25(9):1020-1032, September 2018.

Open
SDC

The mysteries of menopause and urogynecologic health: clinical and scientific gaps

Alperin, Marianna; Burnett, Lindsey; Lukacz, Emily; More

Menopause. 26(1):103-111, January 2019.

Free
SDC

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials

Simon, James A.; Portman, David J.; Kaunitz, Andrew M.; More

Menopause. 20(10):1027-1035, October 2013.

Free

Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)

Cintron, Dahima; Lahr, Brian D.; Bailey, Kent R.; More

Menopause. 25(2):145-153, February 2018.

Open

Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis

McClung, Michael R.; Harvey, Nicholas C.; Fitzpatrick, Lorraine A.; More

Menopause. 25(7):767-771, July 2018.

Open
SDC

Epidemiology of low-energy fracture in Chinese postmenopausal women: changing trend of incidence since menopause and associated risk factors, a national population-based survey

Zhu, Yanbin; Liu, Song; Chen, Wei; More

Menopause. 26(3):286-292, March 2019.

The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy

Constantine, Ginger D.; Simon, James A.; Pickar, James H.; More

Menopause. 24(4):409-416, April 2017.

Open
SDC

Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy

Chan, Jessica L.; Senapati, Suneeta; Johnson, Lauren N.C.; More

Menopause. 26(2):132-139, February 2019.

Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study

Gentry-Maharaj, Aleksandra; Karpinskyj, Chloe; Glazer, Clara; More

Menopause. 22(4):384-390, April 2015.

Open
SDC

Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins

Berglind, Ingegärd Anveden; Andersen, Morten; Citarella, Anna; More

Menopause. 22(4):369-376, April 2015.

Open

Amenorrhea after lung cancer treatment

Cathcart-Rake, Elizabeth J.; Ruddy, Kathryn J.; Gupta, Ruchi; More

Menopause. 26(3):306-310, March 2019.

Clinical management of hypoactive sexual desire disorder

Kingsberg, Sheryl; Faubion, Stephanie

Menopause. 26(2):217-219, February 2019.

Age and leptinemia association with anxiety and depression symptoms in overweight middle-aged women

Naufel, Maria Fernanda; Boldarine, Valter Tadeu; Oyama, Lila Missae; More

Menopause. 26(3):317-324, March 2019.

Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study

Coelingh Bennink, Herjan J.T.; Verhoeven, Carole; Zimmerman, Yvette; More

Menopause. 24(6):677-685, June 2017.

Open

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health

Faubion, Stephanie S.; Larkin, Lisa C.; Stuenkel, Cynthia A.; More

Menopause. 25(6):596-608, June 2018.

Pelvic organ prolapse: from estrogen to pessary

Takacs, Peter; Kozma, Bence; Larson, Kindra

Menopause. 26(2):121-122, February 2019.

Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues

Labrie, Fernand

Menopause. 26(2):220-224, February 2019.

Bazedoxifene-induced vasodilation and inhibition of vasoconstriction is significantly greater than estradiol

Zimmerman, Margaret A.; Hutson, Dillion D.; Mauvais-Jarvis, Franck; More

Menopause. 26(2):172-181, February 2019.

The association of an alpha2C adrenoreceptor gene polymorphism with vasomotor symptoms in African American women

Aharon, Devora A.; Friedman, Elissa Gretz; Overbey, Jessica R.; More

Menopause. 26(3):300-305, March 2019.

SLCO1B1 genetic variation and hormone therapy in menopausal women

Moyer, Ann M.; de Andrade, Mariza; Faubion, Stephanie S.; More

Menopause. 25(8):877-882, August 2018.

Open
SDC

Adaptation and translation of the menopause-specific Utian Quality of Life (UQOL) scale to Yoruba language using middle-aged women attending a clinic in Nigeria

Aberi, Obalowu Ismaila; Okebunor, Odeigah Louis; Moradeyo, Alabi Kola; More

Menopause. 26(3):311-316, March 2019.

Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial

Simon, James A.; Archer, David F.; Kagan, Risa; More

Menopause. 24(9):1003-1010, September 2017.

Open
SDC

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

Portman, David J.; Bachmann, Gloria A.; Simon, James A.; More

Menopause. 20(6):623-630, June 2013.

Free

The WISDOM survey: toward wiser care of women with vulvovaginal atrophy

Shifren, Jan L.

Menopause. 26(2):115-117, February 2019.

A prospective study of inflammatory biomarker levels and risk of early menopause

Bertone-Johnson, Elizabeth R.; Manson, JoAnn E.; Purdue-Smithe, Alexandra C.; More

Menopause. 26(1):32-38, January 2019.

Appropriate evaluation of postmenopausal bleeding

Goldstein, Steven R.

Menopause. 25(12):1476-1478, December 2018.

Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo

Flyckt, Rebecca L.; Liu, James; Frasure, Heidi; More

Menopause. 16(4):680-688, July-August 2009.

A sex-specific dose-response curve for testosterone: could excessive testosterone limit sexual interaction in women?

Krapf, Jill M.; Simon, James A.

Menopause. 24(4):462-470, April 2017.

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

Portman, David J.; Kaunitz, Andrew M.; Kazempour, Kazem; More

Menopause. 21(10):1082-1090, October 2014.

Open
SDC

One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus

Simon, James A.; Lin, Vivian H.; Radovich, Cathy; More

Menopause. 20(4):418-427, April 2013.

Free

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause

Pinkerton, JoAnn V.; Joffe, Hadine; Kazempour, Kazem; More

Menopause. 22(1):50-58, January 2015.

Open

The cross-sectional association between chemerin and bone health in peri/pre and postmenopausal women: results from the EPIC-Potsdam study

Menzel, Juliane; Biemann, Ronald; Aleksandrova, Krasimira; More

Menopause. 25(5):574-578, May 2018.

Open

A theory of eu-estrogenemia: a unifying concept

Turner, Ralph J.; Kerber, Irwin J.

Menopause. 24(9):1086-1097, September 2017.

Open

Status of bone strength and factors associated with vertebral fracture in postmenopausal women with type 2 diabetes

Chen, Fang-Ping; Kuo, Sheng-Fong; Lin, Yu-Ching; More

Menopause. 26(2):182-188, February 2019.

Hormone therapy in postmenopausal women associated with risk of stroke and venous thromboembolism: a population-based cohort study in Taiwan

Chang, Wei-Chuan; Wang, Jen-Hung; Ding, Dah-Ching

Menopause. 26(2):197-202, February 2019.

29th Annual Meeting of The North American Menopause Society October 3-6, 2018, San Diego, CA

Menopause. 25(12):1480-1522, December 2018.

Hormone therapy and carotid intima-media thickness: the thick and thin of it

Shufelt, Chrisandra L.; Merz, C. Noel Bairey

Menopause. 26(1):5-6, January 2019.

The 2017 hormone therapy position statement of The North American Menopause Society

Menopause. 25(11):1362-1387, November 2018.

Factors associated with age at natural menopause among elderly women in São Paulo, Brazil

Lay, Alejandra Andrea Roman; Duarte, Yeda Aparecida de Oliveira; Filho, Alexandre Dias Porto Chiavegatto

Menopause. 26(2):211-216, February 2019.

Time since menopause and skeletal muscle estrogen receptors, PGC-1α, and AMPK

Park, Young-Min; Pereira, Rocio I.; Erickson, Christopher B.; More

Menopause. 24(7):815-823, July 2017.

Open

Compounded non-FDA–approved menopausal hormone therapy prescriptions have increased: results of a pharmacy survey

Pinkerton, JoAnn V.; Constantine, Ginger D.

Menopause. 23(4):359-367, April 2016.

Open
SDC

Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial

Huang, Grace; Basaria, Shehzad; Travison, Thomas G.; More

Menopause. 21(6):612-623, June 2014.

23rd Annual Meeting of The North American Menopause Society October 3–October 6, 2012, Orlando, FL

Menopause: The Journal of The North American Menopause Society. 19(12):1365-1404, December 2012.

Midlife women: symptoms associated with menopausal transition and early postmenopause and quality of life

Greenblum, Catherine A.; Rowe, Meredeth A.; Neff, Donna Felber; More

Menopause: The Journal of The North American Menopause Society. 20(1):22-27, January 2013.

The Women's Health Initiative: evolving insights over 15 years

Kling, Juliana M.; Manson, JoAnn E.

Menopause. 24(4):355-357, April 2017.

Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization

Karim, Roksana; Dell, Richard M.; Greene, Denise F.; More

Menopause. 18(11):1172-1177, November 2011.

Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women

Pinkerton, JoAnn V.; Santoro, Nanette

Menopause. 22(9):926-936, September 2015.

Open

Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy

Pinkerton, JoAnn V.; Pickar, James H.

Menopause. 23(2):215-223, February 2016.

Open

Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study: Erratum

Menopause. 25(10):1169, October 2018.

Free

Decreasing sleep-related symptoms through increasing physical activity among Asian American midlife women

Chee, Wonshik; Kim, Sangmi; Tsai, Hsiu-Min; More

Menopause. 26(2):152-161, February 2019.

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial Erratum

Menopause. 22(2):245, February 2015.

Free

Time to advocate for better science, and better treatments for women

Mitchell, Caroline M.; Reed, Susan D.; Guthrie, Katherine A.

Menopause. 25(10):1065-1068, October 2018.

Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial

Lucas, Michel; Asselin, Geneviève; Mérette, Chantal; More

Menopause. 16(2):357-366, March 2009.

Changes in adiposity and other factors in relation to age at natural menopause: analyses from the coronary artery risk development (CARDIA) study

Costanian, Christy; McCague, Hugh; Edgell, Heather; More

Menopause. 26(2):162-171, February 2019.

Effects of physiologic testosterone therapy on quality of life, self-esteem, and mood in women with primary ovarian insufficiency

Guerrieri, Gioia M.; Martinez, Pedro E.; Klug, Summer P.; More

Menopause. 21(9):952-961, September 2014.

Effects of combined ovariectomy with dexamethasone on rat lumbar vertebrae

Ren, Hui; Liang, De; Shen, Gengyang; More

Menopause. 23(4):441-450, April 2016.

Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate?

Lau, Clara B. S; Ho, Tony C. Y; Chan, Terry W. L; More

Menopause. 12(6):734-740, November-December 2005.

Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse

Mao, Meng; Ai, Fangfang; Kang, Jia; More

Menopause. 26(2):145-151, February 2019.

The unintended sexual health consequences of risk-reducing surgery: we must do more!

Larkin, Lisa; Kingsberg, Sheryl A.

Menopause. 26(2):118-120, February 2019.

Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women

Huang, Alison J.; Gregorich, Steven E.; Kuppermann, Miriam; More

Menopause. 22(2):144-154, February 2015.

In people living with HIV (PLWH), menopause (natural or surgical) contributes to the greater symptom burden in women: results from an online US survey

Schnall, Rebecca; Jia, Haomiao; Olender, Susan; More

Menopause. 25(7):744-752, July 2018.

Validation of the 10-item Cervantes Scale in middle-aged Portuguese women: paper-and-pencil and online format assessment of menopause-related symptoms

Pimenta, Filipa; Albergaria, Rita; Marôco, João; More

Menopause. 26(2):203-210, February 2019.

Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy

Dimitrakakis, Constantine; Jones, Robert A.; Liu, Aiyi; More

Menopause. 11(5):531-535, September-October 2004.

Contraception for midlife women: a review

Miller, Taniqua A.; Allen, Rebecca H.; Kaunitz, Andrew M.; More

Menopause. 25(7):817-827, July 2018.

Demands for perimenopausal health care in women aged 40 to 60 years—a hospital-based cross-sectional study in Shanghai, China

Huang, Cheng; Zheng, Yanwei; Zhu, Liping; More

Menopause. 26(2):189-196, February 2019.

Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications

Glaser, Rebecca L.; York, Anne E.; Dimitrakakis, Constantine

Menopause. 24(7):859-864, July 2017.

Open

Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight, postmenopausal women

Soni, Amy C.; Conroy, Molly B.; Mackey, Rachel H.; More

Menopause. 18(3):296-301, March 2011.

Middle-aged women’s decisions about body weight management: needs assessment and testing of a knowledge translation tool

Stacey, Dawn; Jull, Janet; Beach, Sarah; More

Menopause. 22(4):414-422, April 2015.

Open

Journal Logo

Secondary Logo

Login

Register for a free account

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

In Brief:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

In Brief: